Insights
Insights From Our Experts
Articles
Upcoming PharmaVOICE Panel – Next Gen Patient Services Models
With increasingly less face-to-face patient interaction, manufacturers need to rethink traditional solutions in order to alleviate access barriers. Despite best efforts, prescription rates continue to drop as newly launched products experience increased patient drop-off; and companies…
Key Factors to Obtaining Reimbursement for Digital Therapeutics in the U.S.
Posted on February 4, 20212/4/21
While wellness apps have been successful in a direct-to-consumer model, many digital therapeutics (DTx) providers are working to obtain reimbursement from U.S. payers. In a heterogenous payer ecosystem, the key question is how to obtain broad…
A Paul Simms Favorite: EVERSANA makes the list for 2021 Predictions
“Imagine there was a third way … an equivalent to the Apple App Store in our industry … maybe that model could start working in pharma; and, in fact, it is.” For pharmaceutical influencer Paul Simms,…
Leveraging Innovative Technology to Improve the Patient Journey
Commercial teams cannot afford to misinterpret the patient and product journeys. Over 50% of new launches fail to meet market forecasts. In addition, newly launched products are experiencing increased patient drop-off due to many U.S. market…
Under the Biden Team & Beyond COVID … What Lies Ahead for Healthcare
Posted by
Dr. Richard Stefanacci on January 29, 20211/29/21
While the obvious healthcare focus for the new Biden/Harris Administration will be on controlling the COVID-19 pandemic, it’s a critical time to assess what lies beyond COVID for their attention. To gain a sense of what’s…
Transforming Commercialization With Industry-Leading Partnerships
Healthcare innovation is being intensified as the industry rushes to find solutions to the pandemic, while furthering research in rare and complex diseases. As pharma companies reignite clinical development, streamlining commercialization is crucial in bridging the…
The 10-Year Test: Is It Possible to Plan Launch During Clinical Development?
Time and strategy are keys to launching in an overwhelmed, unpredictable market. Pharmaceutical companies in mid-development of a drug need to look ahead at their launch strategy options and consider what market conditions could look like by the time they’re ready to commercialize their product. By evaluating the value…
Moving Forward in Pharma: Reigniting Revenue for Mature Brands
The world will be moving forward with immeasurable effects from the COVID-19 pandemic, as will the pharmaceutical industry. Fully understanding the impact that the pandemic will have on pharma will take years; however, there are future…
When America Sneezes, the World Catches a Cold: How Changes to U.S. Drug Pricing Will Affect the Globe
Posted on January 18, 20211/18/21
Through an intense U.S. election season, there is one issue that patrons of the right and left agreed on: The cost of prescription drugs is viewed as unfair and unsustainable. With President Joe Biden in office,…
How Better Alignment Propels Your Brand’s Success
As pharma companies race to keep up with today’s market, your brand’s team can’t afford to be out of sync. Yet inefficiencies and miscommunications are common throughout the commercialization process — wasting valuable resources, creating confusion among key stakeholders and slowing…